To see all protocols that comply with the WHO Essential Medicine List 

Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more

 

Latest news

View all news

See eviQ's Program Director Professor Robyn Ward talk about how and why eviQ was developed, its purpose and the governance processes that ensure its high quality content.

The new cellular therapies section is accessible through the Haematology and BMT menu on the homepage. Currently, there are 2 cellular therapy protocols: ID 3832 B-cell acute lymphoblastic leukaemia tisagenlecleucel and; ID 3839 Diffuse large B-cell lymphoma tisagenlecleucel. You can also find relevant clinical resources in our BMT & cellular therapies section.

We have created a specific page to link relevant COVID-19 resources for cancer health professionals and people with cancer and their carers.

This rapid learning provides an overview of pancreatic cancer, its impact on Australians and available treatment options.